More forecasts: Atlanta 30 day forecast
Redwood City Biotech Scores As Neurocrine Drops $2.9 Billion On Prader‑Willi Drug
Apr 06, 2026
Neurocrine will pay $53 a share to buy Redwood City’s Soleno for about $2.9B, adding VYKAT XR — the first FDA‑approved treatment for hyperphagia in Prader‑Willi syndrome.
EPA’s Quiet Plastic Plant Rollback Has San Diego Holding Its Breath
Apr 04, 2026
EPA has quietly asked whether to exempt some plastic “advanced recycling” plants from Clean Air Act rules, a move that drew industry praise and activist alarm. A public hearing and comment period are now open.












